Cargando…
Optimal duration of a first-line palliative chemotherapy in disseminated colorectal cancer – a review of the literature from a developing country perspective
We still do not know whether the presently used protocol of the first-line palliative treatment of disseminated colorectal cancer (FOLFOX/FOLFIRI protocol) allows maximization of therapeutic response and minimization of side effects. No-one has verified whether continuation of the first-line chemoth...
Autores principales: | Rogowski, Wojciech, Sulżyc-Bielicka, Violetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013682/ https://www.ncbi.nlm.nih.gov/pubmed/27647984 http://dx.doi.org/10.5114/wo.2016.61561 |
Ejemplares similares
-
E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy
por: Sulzyc-Bielicka, Violetta, et al.
Publicado: (2016) -
Colorectal cancer and Cryptosporidium spp. infection
por: Sulżyc-Bielicka, Violetta, et al.
Publicado: (2018) -
Expression of p21(WAF1) in Astler–Coller stage B2 colorectal cancer is associated with survival benefit from 5FU-based adjuvant chemotherapy
por: Sulzyc-Bielicka, Violetta, et al.
Publicado: (2011) -
Colorectal cancer and Blastocystis sp. infection
por: Sulżyc-Bielicka, Violetta, et al.
Publicado: (2021) -
Thymidylate synthase expression and p21(WAF1)/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy
por: Sulzyc-Bielicka, Violetta, et al.
Publicado: (2013)